Literature DB >> 8376312

Zinc-enhanced cytotoxicity in cisplatin sensitive and resistant human ovarian cancer cells.

D L Nicholson, R H Maier, W J Pories.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8376312     DOI： 10.1007/bf02634548

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  5 in total

1.  Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model.

Authors:  K S Albain; L J Swinnen; L C Erickson; P J Stiff; R I Fisher
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Resistance to cisplatin and analogues: mechanisms and potential clinical implications.

Authors:  A de Graeff; R J Slebos; S Rodenhuis
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.

Authors:  R P Perez; P J O'Dwyer; L M Handel; R F Ozols; T C Hamilton
Journal:  Int J Cancer       Date:  1991-05-10       Impact factor: 7.396

4.  Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells.

Authors:  P A Andrews; M P Murphy; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma.

Authors:  E F McClay; M J Mastrangelo; J D Sprandio; R E Bellet; D Berd
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860
  5 in total
  1 in total

1.  The cytotoxic interaction of inorganic trace elements with EDTA and cisplatin in sensitive and resistant human ovarian cancer cells.

Authors:  R H Maier; S M Purser; D L Nicholson; W J Pories
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-03       Impact factor: 2.416
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.